Overview

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Treatments:
Timolol